会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Long acting compositions comprising zidovudine and lamivudine
    • 包含齐多夫定和拉米夫定的长效组合物
    • US20050175694A1
    • 2005-08-11
    • US10512464
    • 2002-04-23
    • Himadri SenSurva Jayanthi
    • Himadri SenSurva Jayanthi
    • A61K9/20A61K9/22A61K31/7068A61K31/7072A61P31/18
    • A61K9/205A61K9/2054A61K9/2059A61K31/7068A61K31/7072A61K2300/00
    • A pharmaceutical composition in the form of a tablet for controlled release of active ingredient(s) comprises lamivudione, zidovudine or combination of lamivudine and zidovudine or their pharmaceutically acceptable derivatives, and a mixture of hydrophilic polymers selected from the group consisting of at least one hydroxypropyl methylcellulose, at least one sodium alginate and at least one guar gum as controlled release matrix and a pharmaceutically acceptable calcium salt as a matrix stabilizer. The composition may also contain one or more of a water soluble and/or water dispersible diluent, wherein the quantities of the hydrophilic polymers, the calcium salt and water soluble and/or water dispersible diluents are such that the therapeutically effective active ingredient(s) is released at a rate suitable for once daily administration of the pharmaceutical composition. The tablets may be coated with a water soluble polymeric film coat.
    • 用于控制释放活性成分的片剂形式的药物组合物包括拉米夫定,齐多夫定或拉米夫定和齐多夫定或其药学上可接受的衍生物的组合,以及选自至少一种羟丙基 甲基纤维素,至少一种藻酸钠和至少一种瓜尔胶作为控释基质和药学上可接受的钙盐作为基质稳定剂。 组合物还可以含有一种或多种水溶性和/或水分散性稀释剂,其中亲水性聚合物,钙盐和水溶性和/或水分散性稀释剂的量使得治疗有效的活性成分 以适合于每日一次给予药物组合物的速率释放。 片剂可以用水溶性聚合物膜包衣包衣。